Search Results - Thomas H. Sharp
- Showing 1 - 7 results of 7
-
1
-
2
-
3
-
4
-
5
Complement is activated by elevated IgG3 hexameric platforms and deposits C4b onto distinct antibody domains by Leoni Abendstein, Douwe J. Dijkstra, Rayman T. N. Tjokrodirijo, Peter A. van Veelen, Leendert A. Trouw, Paul J. Hensbergen, Thomas H. Sharp
Published in Nature Communications (2023-07-01)Get full text
Article -
6
Targeted complement inhibition using bispecific antibodies that bind local antigens and endogenous complement regulators by Haiyu Wang, Fleur S. van de Bovenkamp, Douwe J. Dijkstra, Leoni Abendstein, Nicole V. Borggreven, Jos Pool, Rob Zuijderduijn, Christoph Gstöttner, Kyra A. Gelderman, Timon Damelang, Timon Damelang, Gestur Vidarsson, Gestur Vidarsson, Anna M. Blom, Elena Domínguez-Vega, Paul W. H. I. Parren, Paul W. H. I. Parren, Thomas H. Sharp, Leendert A. Trouw
Published in Frontiers in Immunology (2024-05-01)Get full text
Article -
7
Germline variant affecting p53β isoforms predisposes to familial cancer by Stephanie A. Schubert, Dina Ruano, Sebastien M. Joruiz, Jordy Stroosma, Nikolina Glavak, Anna Montali, Lia M. Pinto, Mar Rodríguez-Girondo, Daniela Q. C. M. Barge-Schaapveld, Maartje Nielsen, Bernadette P. M. van Nesselrooij, Arjen R. Mensenkamp, Monique E. van Leerdam, Thomas H. Sharp, Hans Morreau, Jean-Christophe Bourdon, Noel F. C. C. de Miranda, Tom van Wezel
Published in Nature Communications (2024-09-01)Get full text
Article
